2024 Annual Event Speakers

2024 Earl Bakken Speaker

Bin He, Ph.D.

Trustee Professor, Biomedical Engineering, Electrical & Computer Engineering, Neuroscience Institute

Carnegie Mellon University

Bin He is the Trustee Professor of Biomedical Engineering, Professor of the Neuroscience Institute, and Professor by courtesy of Electrical and Computer Engineering at Carnegie Mellon University. Dr. He has made significant research and education contributions to the field of neuroengineering and biomedical imaging, including functional biomedical imaging, noninvasive brain-computer interface (BCI), and noninvasive neuromodulation. His pioneering research has helped transforming electroencephalography from a 1-dimensional detection technique to 3-dimensional neuroimaging modality. His lab demonstrated for the first time for humans to fly a drone and control a robotic arm just by thinking about it using a noninvasive BCI. He has contributed significantly to neuroengineering education including editing the first textbook in Neural Engineering (1st Edition, 2005; 2nd Edition, 2013; 3rd Edition, 2020), and led multiple NIH and NSF training grants in neuroengineering.

Dr. He has received a number of awards including the IEEE Biomedical Engineering Award, the IEEE BMBS William J Morlock Award, the Academic Career Achievement Award and Distinguished Service Award from the IEEE Engineering in Medicine and Biology Society, the Established Investigator Award from the American Heart Association, NSF CAREER Award, among others. He is an elected Fellow of International Academy of Medical and Biological Engineering (IAMBE), American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), and IEEE. Dr. He served as a Past President of the IEEE Engineering in Medicine and Biology Society, the International Society for Functional Source Imaging, the International Society on Bioelectromagnetism, and as Chair of Publications Committee of AIMBE. Dr. He served as the Editor-in-Chief of IEEE Transactions on Biomedical Engineering from 2013-2018, and during his tenure, the journal’s impact factor has nearly doubled. Dr. He has served as the Chair of the International Academy of Medical and Biological Engineering from 2018-2021. Dr. He has been a Member of NIH BRAIN Initiative Multi-Council Working Group from 2014-2019.

From February 2018 to February 2020, Bin He served as the Head of the Department of Biomedical Engineering at Carnegie Mellon University. Over the three years, the department has made substantial progress – research expenditure increased by 60%, PhD student population increased by 50%, graduate underrepresented minority student population nearly doubled, and graduate program ranking increased from the top 26th to the 22nd to the 17th according to US News and World Report. In 2018, Dr. He founded the Carnegie Mellon Forum on Biomedical Engineering series and chaired the first 3 Forums in 2018, 2019, and 2020, respectively.


Professor Bin He’s research is centered around neuroengineering with focus to functional neuroimaging, neural interfacing and neuromodulation. His lab is developing noninvasive dynamic brain imaging technology for studying mechanisms of motor and visual systems, and aiding detection, diagnosis, and management of various brain disorders. An active research project is on developing novel techniques for localizing and imaging epileptic seizures from noninvasive EEG, MEG, and intracranial EEG to aid surgical resection. Functional brain networks are imaged from EEG, MEG and functional MRI to understand brain functions and aid clinical management of brain disorders. A major thrust area of Dr. He’s research is to develop noninvasive mind-controlled brain-computer interface for aiding disabled patients, including developing novel engineering solutions using motor imagery, spatial attention, etc. and develop enabling techniques to make BCI a broadly used assistive technology by the general population.

Research Interests: electrophysiological source imaging; brain-computer interface; neuromodulation; functional neuroimaging; tissue electrical property imaging

Awards and Recognition

  • IEEE EMBS William J Morlock Award, 2019
  • Chair, International Academy of Medical and Biological Engineering, 2018 – 2021
  • Editor-in-Chief: IEEE Transactions on Biomedical Engineering, 2013 – 2018
  • IEEE Biomedical Engineering Award, 2017
  • Academic Career Achievement Award, IEEE Engineering in Medicine and Biology Society, 2015
  • Distinguished Service Award, IEEE Engineering in Medicine and Biology Society, 2014
  • President, IEEE Engineering in Medicine and Biology Society, 2009 – 2010

Michael R. King, Ph.D.

Chair, AIMBE College of Fellows

Michael R. King is the J. Lawrence Wilson Professor and Department Chair of Biomedical Engineering at Vanderbilt University. Previously he was the Daljit S. and Elaine Sarkaria Professor at Cornell University. He completed a PhD in chemical engineering at the University of Notre Dame and postdoctoral training in bioengineering at the University of Pennsylvania. He has written textbooks on the subjects of statistical methods and microchannel flows, and has received several awards including the NSF CAREER Award, Outstanding Research Awards from the American Society of Mechanical Engineers and the American Society of Clinical Chemistry, and was a James D. Watson Investigator of New York State. King is a Fellow of the American Institute for Medical and Biological Engineering, the Biomedical Engineering Society, and the International Academy of Medical and Biological Engineering, and serves as Vice President of the International Society of Bionic Engineering. He is the Editor-in-Chief of Cellular and Molecular Bioengineering, an official journal of the Biomedical Engineering Society, and serves as the Chair-Elect of the Biomedical Engineering Council of Chairs.

The King Lab works at the interface between Cellular Engineering, Drug Delivery, and Nanotechnology. They employ tools and concepts from engineering to understand biomedically important processes that occur in the bloodstream, including cancer metastasis, inflammation, and thrombosis. They have found that tumor cells in the circulation can mimic the physical mechanisms used by white blood cells to traffic through the body and adhere to the blood vessel wall, and have explored strategies to interrupt this metastasis process by targeting specific adhesion receptors. The selectin adhesion receptors important in leukocyte, stem cell, and CTC trafficking have unique biophysics that make them ideal for targeted drug delivery. The King Lab has pioneered the use of selectin proteins to deliver apoptosis death signals to tumor cells in flowing blood, and to deliver therapeutic cargo (e.g., siRNA, chemotherapeutics) encapsulated in nanoscale liposomes. The King lab is currently testing these novel cancer therapies in mouse models of metastatic breast and prostate cancer through the use of whole body luminescence imaging, and in blood samples collected from human volunteers diagnosed with cancer at various stages.

Michael King has been married to Cynthia Reinhart-King, Cornelius Vanderbilt Professor of Engineering, since 2002, and together they have two sons: Simon (age 13) and Julian (age 6), and a 15 year old cockapoo named Lady Mix-a-Lot King. They live in Brentwood, in a home last owned by CJ2K.

Outside of work and family interests, Mike is the founder of VIBE: the Vanderbilt Initiative of Biofunky Engineers, a musical group of biomedical engineering faculty and graduate students who have performed since 2017 on and off the Vanderbilt campus, and live over the air on Radio Free Nashville. Other interests include: being a fanatical lacrosse dad, keeping fit, and wheeling around town in a Jeep Wrangler with no doors.

Selected Honors, Awards, and Activities

  • Editor-in-Chief, Cellular and Molecular Bioengineering
  • Fellow, Biomedical Engineering Society (BMES)
  • Fellow, American Institute for Medical and Biological Engineering (AIMBE)
  • Outstanding Speaker Award, American Association of Clinical Chemistry
  • Fiona Ip Li ‘78 and Donald Li ’75 Award for Teaching Excellence, Cornell University
  • Professor of the Year in Engineering, University of Rochester
  • National Science Foundation CAREER Award
  • James D. Watson Investigator Award, New York State Office for Science, Technology and Academic Research (NYSTAR)
  • Whitaker Investigator, The Whitaker Foundation
  • National Academy of Inventors Fellow

Joyce Y. Wong, Ph.D.

President, American Institute for Medical and Biological Engineering (AIMBE)

Dr. Wong is a Professor of Biomedical Engineering and Materials Science and Engineering and an Inaugural Term Distinguished Professor of Engineering at Boston University. She is also the Inaugural Director of ARROWS, Office of the Provost, focused on promoting women in STEM at BU. She is an elected Fellow of the Biomedical Engineering Society (BMES), the American Institute of Medical and Biological Engineering (AIMBE), and the American Association for the Advancement of Science (AAAS).

RESEARCH FOCUS: Development of novel biomaterials to detect and treat disease. Elucidation of fundamental molecular, cellular, and colloidal/interfacial processes for specific biomedical applications.

CURRENT PROJECTS: Pediatric vascular tissue engineering; Vascularized tissue engineering; Theranostics for cardiovascular disease and cancer; In vitro models of cancer metastasis.

Honors and Awards

  • Fellow, National Academy of Inventors, 2020
  • Fellow, American Academy for the Advancement of Science, 2017
  • BU Inaugural Term Distinguished Professor of Engineering, 2014
  • Fellow, Biomedical Engineering Society, 2013
  • Collaborator of the Year Award, BU Department of Medicine, 2012
  • Hartwell Individual Biomedical Research Award, 2009
  • Fellow, American Institute for Medical and Biological Engineering, 2009
  • NSF CAREER Award, 2000

Dawn Beraud, Ph.D.

Executive Director, American Institute for Medical and Biological Engineering (AIMBE)

Dawn Beraud, Ph.D., serves as the Executive Director of AIMBE. As a science policy leader with senior government experience and a keen understanding of Capitol Hill processes, Dr. Beraud brings to AIMBE her passion for helping scientists join the conversation and influence policy decisions. She directs AIMBE’s strategic planning and partners with Fellows to provide advocacy leadership in medical and biological engineering. Dr. Beraud joins AIMBE from the National Institute on Aging (NIA) at NIH, where she led congressional relations and external outreach for almost a decade. Prior to joining the NIA, Dr. Beraud worked on autism spectrum disorder (ASD) research policy at the National Institute of Mental Health. Dr. Beraud received a B.S. in psychology from the University of Florida and a Ph.D. in neuroscience from Georgetown University.